Skip to main content
Drug Design, Development and Therapy logoLink to Drug Design, Development and Therapy
. 2022 Aug 11;16:2681–2682. doi: 10.2147/DDDT.S385435

Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial [Corrigendum]

PMCID: PMC9377341  PMID: 35978858

Deng Y, Qin Z, Wu Q, et al. Drug Des Devel Ther. 2022;16:2439‒2451.

The authors have informed the journal that Remimazolam Tosilate was used in this study, not Remimazolam Besylate as indicated throughout the paper.

The authors apologize for any confusion this may have caused.


Articles from Drug Design, Development and Therapy are provided here courtesy of Dove Press

RESOURCES